In the case of cisplatin/CIS, TRIM28-KO clones also exhibited significantly higher IC50 values compared to the Control group (ANOVA F(2,9) = 5.18, p = 0.03; Tukey’s test: p = 0.05). This evidence concerns the gene TRIM28 and in situ carcinoma.